Plasma plastin-3: A tumor marker in patients with non-small-cell lung cancer treated with nivolumab

Plastin-3 (PLS3) is a circulating tumor cell marker associated with aggressive cancer phenotypes. The present study aimed to investigate the usability of plasma PLS3 concentration in assessing the diagnosis, prognosis and sensitivity to treatment in patients with non-small-cell lung cancer (NSCLC) t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Kuriyama, Kengo, Yokobori, Takehiko, Sohda, Makoto, Nakazawa, Nobuhiro, Yajima, Toshiki, Naruse, Ichiro, Kuwano, Hiroyuki, Shirabe, Ken, Kaira, Kyoichi, Saeki, Hiroshi
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2021
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7681218/
https://ncbi.nlm.nih.gov/pubmed/33240417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12272
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars